These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2437109)

  • 1. Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope.
    Kennedy RC; Dreesman GR; Chanh TC; Boswell RN; Allan JS; Lee TH; Essex M; Sparrow JT; Ho DD; Kanda P
    J Biol Chem; 1987 Apr; 262(12):5769-74. PubMed ID: 2437109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.
    Gnann JW; Schwimmbeck PL; Nelson JA; Truax AB; Oldstone MB
    J Infect Dis; 1987 Aug; 156(2):261-7. PubMed ID: 2439614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.
    Palker TJ; Matthews TJ; Clark ME; Cianciolo GJ; Randall RR; Langlois AJ; White GC; Safai B; Snyderman R; Bolognesi DP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2479-83. PubMed ID: 2436231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS
    J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
    de Wolf F; Meloen RH; Bakker M; Barin F; Goudsmit J
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1261-7. PubMed ID: 1710645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.
    Javaherian K; Langlois AJ; Schmidt S; Kaufmann M; Cates N; Langedijk JP; Meloen RH; Desrosiers RC; Burns DP; Bolognesi DP
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1418-22. PubMed ID: 1371358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
    Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide.
    Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC
    J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly immunoreactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional immunochemical methods.
    Närvänen A; Korkolainen M; Kontio S; Suni J; Turtianen S; Partanen P; Soos J; Vaheri A; Huhtala ML
    AIDS; 1988 Apr; 2(2):119-23. PubMed ID: 3132938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
    Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The peptide mapping of the E2-2 and E2-6 sites of the E2 glycoprotein in the Venezuelan equine encephalomyelitis virus].
    Sviatchenko VA; Pereboev AV; Agapov EV; Razumov IA; Sabirov AN; Mizenko GA; Samukov VV; Loktev VB
    Vopr Virusol; 1993; 38(4):162-7. PubMed ID: 7694427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
    Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
    Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.
    Gnann JW; Nelson JA; Oldstone MB
    J Virol; 1987 Aug; 61(8):2639-41. PubMed ID: 2439707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope characterization by modifications of antigens and by mapping on resin-bound peptides. Discriminating epitopes near the C-terminus and N-terminus of Escherichia coli ribosomal protein S13.
    Syu WJ; Kahan L
    J Immunol Methods; 1989 Mar; 118(2):153-60. PubMed ID: 2466901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
    Wang JJ; Steel S; Wisniewolski R; Wang CY
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.